Nutritional High (CSE:EAT, OTCQB:SPLIF, FWB:2NU) (“Nutritional High”) and Aura Health Inc. (CSE:BUZZ) (“Aura”) are pleased to announce the development of a framework to bring Nutritional High’s extraction and edibles technology and products to European and Israeli markets.
Nutritional High will work with Aura Health to outfit Aura with the knowledge and expertise to extract cannabis oil utilizing Nutritional High’s cryo ethanol process and other extraction methods. Aura will develop health and wellness products which, in turn, may be licensed to Nutritional High for distribution in the US. Management will work together in the coming months to develop the business plan and financial metrics for this partnership.
Jim Frazier, CEO of Nutritional High, commented, “The Nutritional High team is excited to announce this new venture with our long-time strategic partners, Aura Health. Once finalized, this deal is an opportunity for Nutritional High to expand our reach on an international level while allowing our management team to continue our focus on an increasingly competitive US market. We look forward to advancing this venture with Aura Health and working closely with them to produce high-quality and consistent cannabis oil products for their customers.”
Daniel Cohen, CEO of Aura, added: “This partnership is a natural evolution of our relationship with Nutritional High and it significantly expands the scope of opportunity for both companies. We have made tremendous headway here at Aura in a short time as we have pivoted our focus toward European, Israeli and international markets, and this relationship allows us to leap ahead of many other companies developing a foothold in Europe.”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™ edibles and extracts product line from production to market in California through its wholly owned processor Pasa Verde LLC and distributor Calyx Brands Inc., and Colorado where its products are manufactured by a licensed producer. The Company also owns a 50% interest in The Clinic Effingham (an Illinois dispensary), and is entering the Nevada, Washington State, Oregon and Canadian markets in the near future.
For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit www.nutritionalhigh.com.
About Aura Health Inc.
Aura has entered agreements to acquire a 54% interest in Israeli cannabis producer HollyCanna Inc., and to establish a chain of medical marijuana dispensaries throughout Israel in partnership with medical cannabis activity pioneer Shlomi Sendak. Aura is taking steps to secure cannabis production capabilities and distribution for the European market. In addition, Aura owns a 30% interest in four medical marijuana clinics in Las Vegas, Nevada; Mesa, Arizona; Tucson, Arizona and Hollywood, Florida, respectively, and an option to increase its interest in each such clinic (other than the Nevada clinic) to 51%.
For further information, please contact:
Daniel Cohen, CEO
Aura Health Inc.
– and –
Co-Chairman of the Board
Nutritional High International Inc.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable real estate and raising sufficient financing to complete the Company’s business strategy. There is no certainty that any of these events will occur. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forwardlooking information or to publicly announce the result of any revisions to any of the forwardlooking information contained herein to reflect future results, events or developments, except as required by law.